company background image
0JS logo

MedMen Enterprises DB:0JS Stock Report

Last Price

€0.0072

Market Cap

€16.2m

7D

0%

1Y

-16.3%

Updated

06 Apr, 2024

Data

Company Financials

MedMen Enterprises Inc.

DB:0JS Stock Report

Market Cap: €16.2m

0JS Stock Overview

Operates as a cannabis retailer in the United States. More details

0JS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Revenue has declined by 17.4% over the past year

Shares are highly illiquid

Negative shareholders equity

Does not have a meaningful market cap (€24M)

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

MedMen Enterprises Inc. Competitors

Biofrontera

XTRA:B8FK

€13.5m

SynBiotic

DUSE:SBX

€22.0m

TFF Pharmaceuticals

MUN:0K30

€9.7m

Cantourage Group

XTRA:HIGH

€60.6m

Price History & Performance

Summary of share price highs, lows and changes for MedMen Enterprises
Historical stock prices
Current Share PriceCA$0.0072
52 Week HighCA$0.032
52 Week LowCA$0.0054
Beta1.42
1 Month Change0%
3 Month Change30.91%
1 Year Change-16.28%
3 Year Change-97.67%
5 Year Change-99.71%
Change since IPO-99.80%

Recent News & Updates

Recent updates

Shareholder Returns

0JSDE PharmaceuticalsDE Market
7D0%2.3%1.4%
1Y-16.3%-14.5%9.1%

Return vs Industry: 0JS exceeded the German Pharmaceuticals industry which returned -31.5% over the past year.

Return vs Market: 0JS underperformed the German Market which returned 4.2% over the past year.

Price Volatility

Is 0JS's price volatile compared to industry and market?
0JS volatility
0JS Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 0JS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 0JS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a428n/awww.medmen.com

MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts.

MedMen Enterprises Inc. Fundamentals Summary

How do MedMen Enterprises's earnings and revenue compare to its market cap?
0JS fundamental statistics
Market cap€16.17m
Earnings (TTM)-€132.25m
Revenue (TTM)€110.85m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Is 0JS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0JS income statement (TTM)
RevenueUS$120.12m
Cost of RevenueUS$63.44m
Gross ProfitUS$56.68m
Other ExpensesUS$199.99m
Earnings-US$143.31m

Last Reported Earnings

Mar 25, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.094
Gross Margin47.18%
Net Profit Margin-119.30%
Debt/Equity Ratio-82.3%

How did 0JS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/06 21:51
End of Day Share Price 2024/01/08 00:00
Earnings2023/03/25
Annual Earnings2022/06/25

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedMen Enterprises Inc. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nikolaas FaesBryan Garnier & Co
Matt BottomleyCanaccord Genuity
Pablo ZuanicCantor Fitzgerald & Co.